Marrow transplantation for patients with acute lymphoblastic leukemia in remission. 1979

E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
May 2002, Blood,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
January 1986, Haematologica,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
November 2000, Bone marrow transplantation,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
January 1990, Haematologica,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
November 1992, Leukemia,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
September 1994, Bone marrow transplantation,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
March 1987, Transplantation,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
July 1991, Annals of internal medicine,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
August 1983, Blood,
E D Thomas, and J E Sanders, and N Flournoy, and F L Johnson, and C D Buckner, and R A Clift, and A Fefer, and B W Goodell, and R Storb, and P L Weiden
January 1984, Seminars in hematology,
Copied contents to your clipboard!